Genetic Medicines for Health and Longevity

Oisín has a robust pipeline targeting multiple drivers of age-related conditions.

Oisín Biotechnologies is developing a new class of genetic medicines that target the biology of aging. We don't make pills or supplements, we build powerful, redosable genetic therapies and start with indications regulators already understand, so we can attack the mechanisms of age-related decline on a path that leads to approval.